BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38667326)

  • 1. How ChatGPT performs in Oral Medicine: The case of oral potentially malignant disorders.
    Diniz-Freitas M; Rivas-Mundiña B; García-Iglesias JR; García-Mato E; Diz-Dios P
    Oral Dis; 2024 May; 30(4):1912-1918. PubMed ID: 37794649
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentially Malignant Oral Disorders and Cancer Transformation.
    Ganesh D; Sreenivasan P; Öhman J; Wallström M; Braz-Silva PH; Giglio D; Kjeller G; Hasséus B
    Anticancer Res; 2018 Jun; 38(6):3223-3229. PubMed ID: 29848669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions.
    Warnakulasuriya KA; Johnson NW
    J Oral Pathol Med; 1992 Oct; 21(9):404-8. PubMed ID: 1432735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation.
    Wils LJ; Buijze M; Stigter-van Walsum M; Brink A; van Kempen BE; Peferoen L; Brouns ER; de Visscher JGAM; van der Meij EH; Bloemena E; Poell JB; Brakenhoff RH
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p16 in oral cancer and premalignant lesions.
    Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
    J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine.
    McGregor F; Muntoni A; Fleming J; Brown J; Felix DH; MacDonald DG; Parkinson EK; Harrison PR
    Cancer Res; 2002 Aug; 62(16):4757-66. PubMed ID: 12183435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD.
    Ogmundsdóttir HM; Hilmarsdóttir H; Astvaldsdóttir A; Jóhannsson JH; Holbrook WP
    Eur J Oral Sci; 2002 Jun; 110(3):192-8. PubMed ID: 12120703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
    Sudha VM; Hemavathy S
    Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
    Scheifele C; Schlechte H; Bethke G; Reichart PA
    Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deterministic evolution and stringent selection during preneoplasia.
    Karlsson K; Przybilla MJ; Kotler E; Khan A; Xu H; Karagyozova K; Sockell A; Wong WH; Liu K; Mah A; Lo YH; Lu B; Houlahan KE; Ma Z; Suarez CJ; Barnes CP; Kuo CJ; Curtis C
    Nature; 2023 Jun; 618(7964):383-393. PubMed ID: 37258665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic heterogeneity in pancreatic cancer organoids and its stability with culture.
    Usman OH; Zhang L; Xie G; Kocher HM; Hwang CI; Wang YJ; Mallory X; Irianto J
    NPJ Genom Med; 2022 Dec; 7(1):71. PubMed ID: 36535941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
    Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH
    Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Protocol to Produce Genetically Edited Primary Oral Keratinocytes Using the CRISPR-Cas9 System.
    Niklander SE; Hunter KD
    Methods Mol Biol; 2023; 2588():217-229. PubMed ID: 36418691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral cancer prediction by noninvasive genetic screening.
    Poell JB; Wils LJ; Brink A; Dietrich R; Krieg C; Velleuer E; Evren I; Brouns ER; de Visscher JG; Bloemena E; Ylstra B; Brakenhoff RH
    Int J Cancer; 2023 Jan; 152(2):227-238. PubMed ID: 36069231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific Targeting of Antiapoptotic Bcl-2 Proteins as a Radiosensitizing Approach in Solid Tumors.
    Sobol B; Azzam Nieto O; Eberlein EL; Scherr AL; Ismail L; Kessler A; Nader L; Schwab M; Hoffmeister P; Schmitt N; Jäger D; Welte S; Seidensaal K; Christopoulos P; Heilig C; Kriegsmann K; Fröhling S; Kriegsmann M; Hess J; Köhler BC
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887198
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.